Reviewed by Michael Gill, B. Sc.
25 Crohns Disease Clinical Trials Near Me
Top Hospitals for Crohns Disease Clinical Trials
Image of Cleveland Clinic in Ohio.
Cleveland Clinic
Cleveland
9Active Trials
22All Time Trials for Crohns Disease
2011First Crohns Disease Trial
Image of Gastro Florida in Florida.
Gastro Florida
Clearwater
8Active Trials
15All Time Trials for Crohns Disease
2017First Crohns Disease Trial
Top Cities for Crohns Disease Clinical Trials
Image of New York in New York.
New York
60Active Trials
Lenox Hill HospitalTop Active Site
Crohn's Disease Clinical Trials by Phase of Trial
Phase < 1 Crohn's Disease Clinical Trials
3Active Crohn's Disease Clinical Trials
3Number of Unique Treatments
5Number of Active Locations
Plant-based fasting-mimicking dietSerum Bovine ImmunoglobulinApixaban 2.5 milligram
Crohn's Disease Clinical Trials by Age Group
< 18 Crohn's Disease Clinical Trials
12Active Crohn's Disease Clinical Trials
OzanimodUstekinumabResistant StarchResistant StarchStandard of CareMSC-AFPMICROBIOTAMultimodal intervention consisting of four core components
Most Recent Crohns Disease Clinical Trials
Top Treatments for Crohns Disease Clinical Trials
Treatment Name
Active Crohns Disease Clinical Trials
All Time Trials for Crohns Disease
First Recorded Crohns Disease Trial
Ozanimod
5
5
2018
Ustekinumab
3
24
2013
Mirikizumab
3
5
2016
Resistant Starch
2
2
2020
Mesenchymal stem cells
2
2
2020
Recently Completed Studies with FDA Approved Treatments for Crohns Disease
Treatment
Year
Sponsor
BT-11 1,000 mg
2021
Landos Biopharma Inc.
Risankizumab
2020
AbbVie
SHR0302
2019
Reistone Biopharma Company Limited
UTTR1147A
2019
Genentech, Inc.
Upadacitinib
2017
AbbVie
Fecal Microbial Transplantation
2017
Stony Brook University
Vedolizumab
2017
Takeda

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: November 5th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.